Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of effectiveness and safety of the large-format pRESET 6-50 thrombectomy stent-retriever in the endovascular treatment of ischemic stroke: real-world experiences from two tertiary comprehensive stroke centers.
Kraehling H, Akkurt BH, Elsharkawy M, Schwindt W, Köhler M, Werring N, Masthoff M, Cox A, Minks D, Stracke CP. Kraehling H, et al. Among authors: masthoff m. Front Neurol. 2023 Nov 17;14:1256365. doi: 10.3389/fneur.2023.1256365. eCollection 2023. Front Neurol. 2023. PMID: 38046595 Free PMC article.
Degradable starch microspheres transarterial chemoembolization (DSM-TACE) in patients with unresectable hepatocellular carcinoma: results from the Prospective Multicenter Observational HepaStar Trial.
Collettini F, Andrašina T, Reimer P, Schima W, Stroszczynski C, Lamprecht Y, Auer TA, Rohan T, Wildgruber M, Gebauer B, Masthoff M. Collettini F, et al. Among authors: masthoff m. Eur Radiol. 2024 Dec 19. doi: 10.1007/s00330-024-11272-8. Online ahead of print. Eur Radiol. 2024. PMID: 39702628
Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis.
Schindler P, Kaldewey D, Rennebaum F, Trebicka J, Pascher A, Wildgruber M, Köhler M, Masthoff M. Schindler P, et al. Among authors: masthoff m. J Cancer Res Clin Oncol. 2024 May 6;150(5):235. doi: 10.1007/s00432-024-05722-5. J Cancer Res Clin Oncol. 2024. PMID: 38710956 Free PMC article.
Multiparametric MRI for characterization of the tumour microenvironment.
Hoffmann E, Masthoff M, Kunz WG, Seidensticker M, Bobe S, Gerwing M, Berdel WE, Schliemann C, Faber C, Wildgruber M. Hoffmann E, et al. Among authors: masthoff m. Nat Rev Clin Oncol. 2024 Jun;21(6):428-448. doi: 10.1038/s41571-024-00891-1. Epub 2024 Apr 19. Nat Rev Clin Oncol. 2024. PMID: 38641651 Review.
Imaging-Derived Biomarkers Integrated with Clinical and Laboratory Values Predict Recurrence of Hepatocellular Carcinoma After Liver Transplantation.
Hoang TPT, Schindler P, Börner N, Masthoff M, Gerwing M, von Beauvais P, De Toni EN, Lange CM, Trebicka J, Morgül H, Seidensticker M, Ricke J, Pascher A, Guba M, Ingrisch M, Wildgruber M, Öcal O. Hoang TPT, et al. Among authors: masthoff m. J Hepatocell Carcinoma. 2023 Dec 18;10:2277-2289. doi: 10.2147/JHC.S431503. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 38143909 Free PMC article.
65 results